Resources

How Omega-3 Fatty Acids Helps Prevent Heart Disease

Omega-3 Fish Oil May Lower Blood Viscosity

EPA/DHA • Flow mechanics • Evidence and how to monitor change with MVL’s Blood Viscosity Profile

Omega-3 fatty acids (fish oil) are well known for heart health. Emerging evidence shows they may also reduce whole blood viscosity (WBV)—the “thickness and stickiness” of blood—improving real-world circulation and potentially lowering cardiovascular risk.

Randomized, double-blind study: 1.8 g/day EPA for 7 weeks reduced systolic and diastolic WBV by 15%—with no change in hematocrit or plasma viscosity.[1]

Why Blood Viscosity Matters (and How Omega-3s Help)

Show Section

WBV reflects the resistance the heart must overcome to push blood through vessels. Elevated viscosity increases total peripheral resistance, raises cardiac workload, and can reduce microcirculatory oxygen delivery.

  • Proposed mechanism: Omega-3s incorporate into RBC membranes, improving deformability and reducing aggregation—lowering flow resistance without changing blood volume.
  • Clinical signal: Viscosity improvements may complement lipid and BP management by improving hemodynamics directly.

Key Evidence at a Glance

Show Studies
Selected Studies on Omega-3s, Viscosity & Outcomes
Study Design / Dose Main Finding
Woodcock et al., 1984[1] Double-blind RCT; 1.8 g/day EPA (fish oil) × 7 weeks ↓ Systolic WBV 15% and ↓ Diastolic WBV 15%; no change in hematocrit or plasma viscosity.
GISSI-Prevenzione, 1999[2] Post-MI (n=11,324) omega-3 supplementation ↓ All-cause mortality 20%, ↓ CV death 30%, ↓ sudden cardiac death 45%.
Additional context[3,4] Sports medicine & immunomodulatory literature Supportive mechanistic/adjunctive insights (performance, inflammation).

Who Might Benefit from Viscosity Monitoring?

Show Section
  • Patients initiating or adjusting omega-3 therapy
  • Individuals with cardiovascular, metabolic, or microcirculatory concerns
  • Those with symptoms despite “normal” standard panels (fatigue, cognitive fog, exertional intolerance)

Monitoring Change: MVL’s Blood Viscosity Profile

Show Section
  • Method: Calibrated glass capillary system
  • Outputs: Systolic and diastolic WBV (direct whole-blood behavior)
  • Regulatory: FDA Class I medical device (21 CFR § 862.2920)
  • Billing: Not covered by insurance; provider bills patient directly

Pairing pre/post measurements with omega-3 therapy helps determine whether viscosity meaningfully improves for a given patient.

Practical Notes for Clinicians

Show Section
  • Dose context: The viscosity study used ~1.8 g/day EPA; many protocols individualize EPA/DHA totals based on risk and tolerance.
  • Adjuncts: Consider diet quality, hydration/electrolytes, triglycerides, hematocrit, and inflammatory markers when interpreting WBV.
  • Safety: Screen for anticoagulant use, bleeding risk, fish/shellfish allergy, and quality of supplements (oxidation, purity).

Important Interpretation Notes

Measured parameter, not diagnosis: MVL reports whole blood viscosity to inform clinical decision-making. Results must be interpreted by licensed clinicians in the context of history, exam, and other labs.

References

Show References
  1. Woodcock BE, et al. Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J (Clin Res Ed). 1984;288(6417):592–4.
  2. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction. Lancet. 1999;354(9177):447–55.
  3. Simopoulos AP. Omega-3 fatty acids and athletics. Curr Sports Med Rep. 2007;6(4):230–6.
  4. Johnson AG. Modulation of the immune system by synthetic polynucleotides. Springer Semin Immunopathol. 1979;2:149–68.

Next Step: Objective Monitoring of Omega-3 Response

Show Section

Practitioners: Use WBV pre/post omega-3 therapy to track functional change in blood flow. Contact Client Services to order or discuss interpretation.

Patients: Ask your licensed provider whether WBV testing is appropriate for your heart-health plan. Meridian Valley Lab provides laboratory services only and cannot advise patients directly.

Call: 855.405.8378 | 206.209.4200